NCT04802096 is a NA clinical trial of inspiratory muscle training in Exacerbation Copd, sponsored by National Taiwan University Hospital.

Who is sponsoring NCT04802096?

NCT04802096 is sponsored by National Taiwan University Hospital.

What drugs are being tested in NCT04802096?

Interventions in NCT04802096: inspiratory muscle training, pulmonary rehabilitation.

What condition does NCT04802096 study?

NCT04802096 studies Exacerbation Copd.

Is NCT04802096 still recruiting?

NCT04802096 is currently completed. Last updated 13 February 2023.

Last reviewed 2023-02-13 · How we verify

NCT04802096

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Inspiratory Muscle Training in Addition to Pulmonary Rehabilitation in Patients With COPD Exacerbation

Completed NA Last updated 13 February 2023

What this trial tests

NA trial testing inspiratory muscle training in Exacerbation Copd in 16 participants. Completed in 16 September 2022.

Timeline

15 March 2021

Primary endpoint
16 September 2022

16 September 2022

Quick facts

Lead sponsor	National Taiwan University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	16
Start date	15 March 2021
Primary completion	16 September 2022
Estimated completion	16 September 2022
Sites	1 location across Taiwan

Drugs / interventions tested

inspiratory muscle training
pulmonary rehabilitation

Conditions studied

Exacerbation Copd — all drugs for Exacerbation Copd →

Sponsor

National Taiwan University Hospital

Who can join

20 and older, any sex, with Exacerbation Copd. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Inspiratory muscle weakness, limited functional exercise capacity and worse quality of life have been shown in patients with exacerbation of chronic obstructive pulmonary disease (COPD). Recommendations from clinical practice guideline state that promoting pulmonary rehabilitation after exacerbation can improve the conditions above. Inspiratory muscle training (IMT) has been proven to enhance inspiratory muscle strength and endurance in patient with stable COPD. However, there is less research on whether IMT in addition to pulmonary rehabilitation after exacerbation can benefit inspiratory muscle function, functional exercise capacity and quality of life in patients with COPD. The purpose of this study is to examine the effects of IMT in addition to pulmonary rehabilitation on respiratory muscle function, functional exercise capacity and quality of life in patients with exacerbation of chronic obstructive pulmonary disease.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary disease (COPD).
Ammous O, Feki W, Lotfi T, Khamis AM, et al · · 2023 · cited 72× · PMID 36606682 · DOI 10.1002/14651858.cd013778.pub2

Verify or expand the search:

Other trials of inspiratory muscle training

Trials testing the same drug.

NCT07161219 — Implementation of New Exercise Protocols in Cardiac Rehabilitation. · NA · not yet recruiting
NCT07200037 — Effects of IMT on Weaning and Diaphragmatic Function in PMV Patients · NA · not yet recruiting
NCT07094347 — Effects of Intradialytic Inspiratory Muscle Training on Functional Capacity in Hemodialysis Patients · NA · not yet recruiting
NCT06895304 — Effects of Inspiratory Muscle Fatigue and Warm-up on Respiratory Variables, Handgrip Strength, and Walking Capacity in S · NA · not yet recruiting
NCT06838299 — Two Different Renal Rehabilitation Protocols in Hemodialysis Patients · NA · completed

Other recruiting trials for Exacerbation Copd

Currently open trials in the same condition.

NCT05704881 — Monitoring of the End-tidal Carbon Dioxide (EtCO2) as a Severity Criterion in COPD Exacerbations · recruiting
NCT03033251 — High Flow Nasal Cannula Versus Non-Invasive Ventilation in Exacerbations of Chronic Obstructive Pulmonary Disease · NA · recruiting

Other National Taiwan University Hospital trials

Trials by the same sponsor.

NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04802096 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
Last refreshed: 13 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04802096.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing